AS-1403

N/A

Report date: 2023/01/08 22:50:06

Base Information

Drug NameAS-1403
Drug Alias NameTheraFabAS-1403
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAntisoma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAntisomaF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A